(3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide

C22H22N4O6S2 — CID 92666490

IUPAC(3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide
SMILESCOc1ccc2nc(NC(=O)[C@H]3CCCN(S(=O)(=O)c4ccc5c(c4)oc(=O)n5C)C3)sc2c1
InChIInChI=1S/C22H22N4O6S2/c1-25-17-8-6-15(11-18(17)32-22(25)28)34(29,30)26-9-3-4-13(12-26)20(27)24-21-23-16-7-5-14(31-2)10-19(16)33-21/h5-8,10-11,13H,3-4,9,12H2,1-2H3,(H,23,24,27)/t13-/m0/s1
InChIKeyLUECBTLUYNYGMO-ZDUSSCGKSA-N
MW502.57 g/mol
LogP2.79
Rot. Bonds5

About (3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide

(3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide (PubChem CID 92666490) has the molecular formula C22H22N4O6S2 and a molecular weight of 502.57 g/mol. Its IUPAC name is (3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide.

Molecular Properties

Compound Name(3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide
PubChem CID92666490
Molecular FormulaC22H22N4O6S2
Molecular Weight502.57 g/mol
Exact Mass502.10
IUPAC Name(3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide
SMILESCOc1ccc2nc(NC(=O)[C@H]3CCCN(S(=O)(=O)c4ccc5c(c4)oc(=O)n5C)C3)sc2c1
InChIInChI=1S/C22H22N4O6S2/c1-25-17-8-6-15(11-18(17)32-22(25)28)34(29,30)26-9-3-4-13(12-26)20(27)24-21-23-16-7-5-14(31-2)10-19(16)33-21/h5-8,10-11,13H,3-4,9,12H2,1-2H3,(H,23,24,27)/t13-/m0/s1
InChIKeyLUECBTLUYNYGMO-ZDUSSCGKSA-N
XLogP2.79
TPSA123.74 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds5
Heavy Atoms34
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500502.57
LogP ≤ 52.79
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Analyze (3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide?
The IUPAC name of (3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide (CID 92666490) is (3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide.
What is the SMILES notation for (3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide?
The canonical SMILES for (3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide is COc1ccc2nc(NC(=O)[C@H]3CCCN(S(=O)(=O)c4ccc5c(c4)oc(=O)n5C)C3)sc2c1.
What is the InChIKey of (3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide?
The InChIKey is LUECBTLUYNYGMO-ZDUSSCGKSA-N. The full InChI is InChI=1S/C22H22N4O6S2/c1-25-17-8-6-15(11-18(17)32-22(25)28)34(29,30)26-9-3-4-13(12-26)20(27)24-21-23-16-7-5-14(31-2)10-19(16)33-21/h5-8,10-11,13H,3-4,9,12H2,1-2H3,(H,23,24,27)/t13-/m0/s1.
What are the key properties of (3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide?
(3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide has a molecular weight of 502.57 g/mol, XLogP of 2.79, 5 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-N-(6-methoxy-1,3-benzothiazol-2-yl)-1-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide is sourced from PubChem (CID 92666490), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).